Company
Processa Pharmaceuticals, Inc. (PCSA)
Standardized SEC financial data for Processa Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001533743 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-243.2%
Free cash flow
-$11.4M
Current ratio
2.54×
EPS (diluted)
$-10.36
Ratios for fiscal year 2022, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | — | — | — |
| R&D expense |
Balance sheet
| USD | FY2024 | FY2024 | FY2024 | FY2025 | FY2025 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | $1.2M | — | — | $5.5M |
| Total current assets |
Get PCSA data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/PCSA/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/PCSA/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"